Discontinuation report XIAFLEX
| Report ID | 118623 |
| Drug Identification Number | 02388316 |
| Brand name | XIAFLEX |
| Common or Proper name | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM |
| Company Name | ENDO VENTURES LTD. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM |
| Strength(s) | 0.9MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRALESIONAL INTRALESIONAL |
| Packaging size | 1 Vial |
| ATC code | M09AB |
| ATC description | OTHER DRUGS FOR DISORD. OF THE MUSCULO-SKELET.SYST |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-06-15 |
| Actual discontinuation date | 2020-06-15 |
| Remaining supply date | 2020-06-15 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-06-22 | English | Compare |
| v2 | 2020-06-22 | French | Compare |
Showing 1 to 2 of 2